ARCHIVES

Irinotecan And Carboplatin Improve Response In NSCLC

This article is from The Cancer Letter archive.

Vol. 28 No. 6 | June 24, 2005

Download PDF Visit The Full Archive

Related Articles

Atrix, Sanofi In Marketing Deal For Leuprogel Products.

January 26, 2001

FDA Employee Inspired to Compose an Anthem for the Agency.

August 4, 2006

In Brief: House Hearing On NCI Budget Is March 16; NIH Reauthorization Sent To Senate Floor

February 14, 1992

ODAC’s Dilemma: Proposed Indication Created By Reliance On PSA Screening and Hormonal Treatment

September 23, 2011

Mothers’ Smoking, Depression Influences Teen Smoking

May 28, 2010

President’s FY 1987 Budget Trims NCI 473 Million From 1986 Appropriation; Basic Research Hit Hard

February 7, 1986